Moss Adams Wealth Advisors LLC Immunity Bio, Inc. Transaction History
Moss Adams Wealth Advisors LLC
- $950 Billion
- Q1 2025
Shares
1 transactions
Others Institutions Holding IBRX
# of Institutions
234Shares Held
82.4MCall Options Held
1.02MPut Options Held
2.25M-
Vanguard Group Inc Valley Forge, PA17.3MShares$50.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$33 Million0.0% of portfolio
-
State Street Corp Boston, MA9.79MShares$28.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.01MShares$11.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.84MShares$11.1 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.16B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...